KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Asml Holding (ASML) Shares Outstanding (Diluted Average) (2016 - 2025)

Asml Holding has reported Shares Outstanding (Diluted Average) over the past 17 years, most recently at $452.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 7.63% year-over-year to $452.7 million; the TTM value through Dec 2025 reached $452.7 million, up 7.63%, while the annual FY2025 figure was $452.7 million, 7.63% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $452.7 million at Asml Holding, up from $420.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $499068.4 billion in Q3 2021 and troughed at $406.1 million in Q4 2022.
  • A 5-year average of $131955.5 billion and a median of $452.7 million in 2025 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 8.15% in 2021 and later dropped 14.92% in 2022.
  • Year by year, Shares Outstanding (Diluted Average) stood at $469.5 million in 2021, then decreased by 13.51% to $406.1 million in 2022, then increased by 4.43% to $424.0 million in 2023, then decreased by 0.81% to $420.6 million in 2024, then increased by 7.63% to $452.7 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for ASML at $452.7 million in Q4 2025, $420.6 million in Q4 2024, and $424.0 million in Q4 2023.